144 related articles for article (PubMed ID: 37000897)
1. Immunostimulant In Situ Fibrin Gel for Post-operative Glioblastoma Treatment by Macrophage Reprogramming and Photo-Chemo-Immunotherapy.
Zhang R; Ye Y; Wu J; Gao J; Huang W; Qin H; Tian H; Han M; Zhao B; Sun Z; Chen X; Dong X; Liu K; Liu C; Tu Y; Zhao S
ACS Appl Mater Interfaces; 2023 Apr; 15(14):17627-17640. PubMed ID: 37000897
[TBL] [Abstract][Full Text] [Related]
2. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.
Catania G; Rodella G; Vanvarenberg K; Préat V; Malfanti A
Biomaterials; 2023 Mar; 294():122006. PubMed ID: 36701998
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
4. M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors.
Choo YW; Kang M; Kim HY; Han J; Kang S; Lee JR; Jeong GJ; Kwon SP; Song SY; Go S; Jung M; Hong J; Kim BS
ACS Nano; 2018 Sep; 12(9):8977-8993. PubMed ID: 30133260
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulant Hydrogel-Guided Tumor Microenvironment Reprogramming to Efficiently Potentiate Macrophage-Mediated Cellular Phagocytosis for Systemic Cancer Immunotherapy.
Liang JL; Jin XK; Luo GF; Zhang SM; Huang QX; Lin YT; Deng XC; Wang JW; Chen WH; Zhang XZ
ACS Nano; 2023 Sep; 17(17):17217-17232. PubMed ID: 37584451
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin B-Responsive Programmed Brain Targeted Delivery System for Chemo-Immunotherapy Combination Therapy of Glioblastoma.
Jiang S; Li W; Yang J; Zhang T; Zhang Y; Xu L; Hu B; Li Z; Gao H; Huang Y; Ruan S
ACS Nano; 2024 Feb; 18(8):6445-6462. PubMed ID: 38358804
[TBL] [Abstract][Full Text] [Related]
7. Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth.
Ramesh A; Malik V; Brouillard A; Kulkarni A
J Biomed Mater Res A; 2022 Aug; 110(8):1448-1459. PubMed ID: 35388955
[TBL] [Abstract][Full Text] [Related]
8. PTN-PTPRZ1 signaling axis blocking mediates tumor microenvironment remodeling for enhanced glioblastoma treatment.
Yang M; Wang B; Yin Y; Ma X; Tang L; Zhang Y; Fan Q; Yin T; Wang Y
J Control Release; 2023 Jan; 353():63-76. PubMed ID: 36402232
[TBL] [Abstract][Full Text] [Related]
9. In situ targeting nanoparticles-hydrogel hybrid system for combined chemo-immunotherapy of glioma.
Wang X; Ye L; He W; Teng C; Sun S; Lu H; Li S; Lv L; Cao X; Yin H; Lv W; Xin H
J Control Release; 2022 May; 345():786-797. PubMed ID: 35367277
[TBL] [Abstract][Full Text] [Related]
10. Zwitterionic Injectable Hydrogel-Combined Chemo- and Immunotherapy Medicated by Monomolecular Micelles to Effectively Prevent the Recurrence of Tumor Post Operation.
Wang R; Hu Q; Huang S; Fang Y; Kong X; Kaur P; Zhang J; Wang Y; Liu D; Wu H; Li Y; Ji J; Yang X; Ye L; Zhai G
ACS Appl Mater Interfaces; 2024 Jan; 16(3):4071-4088. PubMed ID: 38194589
[TBL] [Abstract][Full Text] [Related]
11. Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma.
Wang F; Huang Q; Su H; Sun M; Wang Z; Chen Z; Zheng M; Chakroun RW; Monroe MK; Chen D; Wang Z; Gorelick N; Serra R; Wang H; Guan Y; Suk JS; Tyler B; Brem H; Hanes J; Cui H
Proc Natl Acad Sci U S A; 2023 May; 120(18):e2204621120. PubMed ID: 37098055
[TBL] [Abstract][Full Text] [Related]
12. Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy.
Fang Y; Huang S; Hu Q; Zhang J; King JA; Wang Y; Wei Z; Lu J; He Z; Kong X; Yang X; Ji J; Li J; Zhai G; Ye L
ACS Nano; 2023 Dec; 17(24):24883-24900. PubMed ID: 37883579
[TBL] [Abstract][Full Text] [Related]
13. Synergistic reinforcement of immunogenic cell death and transformation of tumor-associated macrophages via an M1-type macrophage membrane-camouflaged ferrous-supply-regeneration nanoplatform.
Wang Y; Xu H; Wang D; Lu Y; Zhang Y; Cheng J; Xu X; Chen X; Li J
Acta Biomater; 2024 Jan; 174():358-371. PubMed ID: 38092253
[TBL] [Abstract][Full Text] [Related]
14. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
[TBL] [Abstract][Full Text] [Related]
15. A Micro-Environment Regulator for Filling the Clinical Treatment Gap after a Glioblastoma Operation.
Zhang Y; You H; Wang Y; Chen Q; Guo Q; Chu Y; Li C; Zhou W; Chen H; Liu P; Wang Y; Zhao Z; Zhou Z; Luo Y; Li X; Zhang T; Song H; Li C; Su B; Sun T; Bi Y; Yu L; Jiang C
Adv Healthc Mater; 2022 Feb; 11(3):e2101578. PubMed ID: 34800085
[TBL] [Abstract][Full Text] [Related]
16. Genetically engineered PD-1 displaying nanovesicles for synergistic checkpoint blockades and chemo-metabolic therapy against non-small cell lung cancer.
Li B; Yang T; Liu J; Yu X; Li X; Qin F; Zheng J; Liang J; Zeng Y; Zhou Z; Liu L; Zhang B; Yao W; Feng Z; Zeng G; Zhou Q; Chen L
Acta Biomater; 2023 Apr; 161():184-200. PubMed ID: 36893957
[TBL] [Abstract][Full Text] [Related]
17. An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.
Liu Y; Li X; Zhang Y; Wang H; Rong X; Peng J; He L; Peng Y
Oncogene; 2019 Dec; 38(49):7399-7415. PubMed ID: 31427735
[TBL] [Abstract][Full Text] [Related]
18. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
19. Engineering Endogenous Tumor-Associated Macrophage-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy.
Wang Y; Yu J; Luo Z; Shi Q; Liu G; Wu F; Wang Z; Huang Y; Zhou D
Adv Mater; 2021 Oct; 33(39):e2103497. PubMed ID: 34387375
[TBL] [Abstract][Full Text] [Related]
20. "Layer peeling" co-delivery system for enhanced RNA interference-based tumor associated macrophages-specific chemoimmunotherapy.
Wang T; Mu W; Li F; Zhang J; Hou T; Pang X; Yin X; Zhang N
Nanoscale; 2020 Aug; 12(32):16851-16863. PubMed ID: 32761008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]